Similarly, in breast cancer, TEA domain transcription factor 4 (TEAD4) binds to the GLUT3 promoter, increasing its expression and thereby contributing to PTX chemoresistance (Li et al. 2022a). Here, SLC2A3 is linked to breast carcinoma.